Browse All

Current Filters

CLEAR FILTER x

TITLE

Evaluation of CHIT1 and SERPINA3 as Candidate Cerebrospinal Fluid Biomarkers of Progressive Biology in Multiple Sclerosis

Author:Bar-Or, Amit   Gelfand, Jeffrey   Agbim, Chinaza   von Büdingen, H.-Christian   Cameron, Briana   Herman, Ann   Jia, Xiaoming   Ramesh, Akshaya   Winger, Ryan   Jiang, Jenny   Harp, Christopher   Cross, Anne   

Session Name:S33: Multiple Sclerosis: Biomarkers in MS  

Topic:Multiple Sclerosis  

Program Number:S33.003  

Author Institution:University of Pennsylvania, Philadelphia, PA  University of California, San Francisco, San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  Genentech, Inc., South San Francisco, CA  Washington University School of Medicine, Clayton, MO  

Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension

Author:Oh, Jiwon   Drulovic, Jelena   Dufek, Michal   Budincevic, Hrvoje   Habek, Mario   Caunt, Maresa   Sierzega, Malgorzata   Clayton, David   Chen, Ying-Fang   Ratchford, Jack   Goodyear, Alexandra   Bar-Or, Amit   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.005  

Author Institution:St. Anne's University Hospital Brno, Teplice, Czech Republic  Solmed Polyclinic and Sveti Duh University Hospital, Zagreb, Croatia  University Hospital Center Zagreb, Zagreb, Croatia  Genentech, Inc., South San Francisco, CA  F. Hoffmann-La Roche Ltd, Basel, Switzerland  University of Pennsylvania, Philadelphia, PA